| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 257,996 | 253,637 | ||
| Investment securities, available-for-sale | 589,023 | 508,359 | ||
| Accounts receivable, net | 115,850 | 107,505 | ||
| Interest and other receivables | 23,588 | 12,181 | ||
| Inventory | 29,097 | 26,124 | ||
| Prepaid expenses | 60,868 | 52,747 | ||
| Total current assets | 1,076,422 | 960,553 | ||
| Property and equipment, net | 3,708 | 3,547 | ||
| Operating lease right-of-use assets | 49,673 | 50,991 | ||
| Intangible assets, net | 111,615 | 114,338 | ||
| Restricted cash | 9,471 | 9,471 | ||
| Long-term inventory | 76,888 | 84,402 | ||
| Other assets | 2,994 | 2,253 | ||
| Total assets | 1,330,771 | 1,225,555 | ||
| Accounts payable | 21,747 | 20,097 | ||
| Accrued liabilities | 334,837 | 309,927 | ||
| Total current liabilities | 356,584 | 330,024 | ||
| Operating lease liabilities | 43,026 | 44,601 | ||
| Other long-term liabilities | 13,889 | 28,548 | ||
| Total liabilities | 413,499 | 403,173 | ||
| Common stock, 0.0001 par value 225,000,000 shares authorized at september 30, 2025 and december 31, 2024 169,146,043 shares and 166,708,856 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 16 | 16 | ||
| Additional paid-in capital | 3,003,221 | 2,980,693 | ||
| Accumulated deficit | -2,086,954 | -2,158,733 | ||
| Accumulated other comprehensive income | 989 | 406 | ||
| Total stockholders equity | 917,272 | 822,382 | ||
| Total liabilities and stockholders equity | 1,330,771 | 1,225,555 | ||
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)